{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:53:41Z","timestamp":1790409221364,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005413","name":"Universit\u00e9 Paris Descartes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jaci.2018.10.064","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T12:50:29Z","timestamp":1544187029000},"page":"524-535.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE"],"prefix":"10.1016","volume":"144","author":[{"given":"Caroline","family":"Galeotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Stephen-Victor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Karnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinmoy","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gilardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan S.","family":"Maddur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Wymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Vonarburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Chevailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan D.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bruhns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srini V.","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeesh","family":"Bayry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.jaci.2018.10.064_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.10.064_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1503\/cmaj.130375","article-title":"Intravenous immunoglobulin as clinical immune-modulating therapy","volume":"187","author":"Gilardin","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.jaci.2018.10.064_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrneurol.2014.253","article-title":"Intravenous immunoglobulin in\u00a0neurology\u2014mode of action and clinical efficacy","volume":"11","author":"Lunemann","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jaci.2018.10.064_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/intimm\/dxx039","article-title":"IVIG-mediated effector functions in autoimmune and inflammatory diseases","volume":"29","author":"Galeotti","year":"2017","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-065X.2011.01023.x","article-title":"Basophils: emerging roles in the pathogenesis of allergic disease","volume":"242","author":"Schroeder","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2018.10.064_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jaci.2017.10.042","article-title":"Multifaceted roles of basophils in health and disease","volume":"142","author":"Karasuyama","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2018.10.064_bib10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.immuni.2012.11.014","article-title":"Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4","volume":"38","author":"Egawa","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.10.064_bib11","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1038\/srep05672","article-title":"Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients","volume":"4","author":"Sharma","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2018.10.064_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12974-017-0818-5","article-title":"Regulatory T cell frequency, but not plasma IL-33 levels, represents potential\u00a0immunological biomarker to predict clinical response to intravenous immunoglobulin therapy","volume":"14","author":"Maddur","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jaci.2018.10.064_bib13","doi-asserted-by":"crossref","first-page":"E2385","DOI":"10.1073\/pnas.1505292112","article-title":"Protection in antibody- and T\u00a0cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs","volume":"112","author":"Fiebiger","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.10.064_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jaci.2016.09.062","article-title":"Human\u00a0basophils may not undergo modulation by DC-SIGN and mannose receptor-targeting immunotherapies due to absence of receptors","volume":"139","author":"Das","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2018.10.064_bib15","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jaci.2003.12.281","article-title":"Expression of CD33-Related siglecs on human eosinophils, basophils and mast Cells","volume":"113","author":"Nutku","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaci.2013.09.029","article-title":"Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells","volume":"133","author":"Massoud","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib17","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/eji.201142318","article-title":"Basophil modulation by cytokine instruction","volume":"42","author":"Voehringer","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1084\/jem.177.3.605","article-title":"Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation","volume":"177","author":"Brunner","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.10.064_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1067\/mai.2002.123532","article-title":"Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3","volume":"109","author":"Yoshimura","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib21","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.4049\/jimmunol.1200968","article-title":"Fc\u03b3 receptors inhibit mouse and human basophil activation","volume":"189","author":"Cassard","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib22","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fc\u03b3 receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"Tackenberg","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.10.064_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cei.12935","article-title":"Fc\u03b3 receptor expression on splenic macrophages in adult immune thrombocytopenia","volume":"188","author":"Audia","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.1686","article-title":"Fc\u00a0receptor gamma-chain, a constitutive component of the IL-3 receptor, is required for IL-3-induced IL-4 production in basophils","volume":"10","author":"Hida","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib25","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1016\/j.febslet.2010.08.006","article-title":"Mast cell signaling: the role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants","volume":"584","author":"Siraganian","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2018.10.064_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2014.199","article-title":"Autoimmunity: basophils in autoimmune and inflammatory diseases","volume":"11","author":"Sharma","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaci.2018.10.064_bib27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41467-018-03129-8","article-title":"Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs","volume":"9","author":"Pellefigues","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2018.10.064_bib28","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.4049\/jimmunol.1301611","article-title":"Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils","volume":"192","author":"Campbell","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib29","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.20101563","article-title":"Inflammatory dendritic cells\u2014not basophils\u2014are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen","volume":"207","author":"Hammad","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.10.064_bib30","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1084\/jem.20100734","article-title":"CD11c depletion severely disrupts Th2 induction and development in\u00a0vivo","volume":"207","author":"Phythian-Adams","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.10.064_bib31","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.3324\/haematol.2016.163451","article-title":"Demystification of enigma on antigen-presenting cell features of human basophils: data from secondary lymphoid organs","volume":"102","author":"Stephen-Victor","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2018.10.064_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1073\/pnas.1615973114","article-title":"Trogocytosis of peptide-MHC class II complexes from dendritic cells confers antigen-presenting ability on basophils","volume":"114","author":"Miyake","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.10.064_bib33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.10.064_bib34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib35","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/ncomms3847","article-title":"Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade","volume":"4","author":"Leyva-Castillo","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2018.10.064_bib36","doi-asserted-by":"crossref","first-page":"eaan0829","DOI":"10.1126\/sciimmunol.aan0829","article-title":"Regulatory T cells induce activation rather than suppression of human basophils","volume":"3","author":"Sharma","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib37","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.4049\/jimmunol.181.9.5981","article-title":"An\u00a0IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor","volume":"181","author":"Suzukawa","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.coi.2010.10.019","article-title":"Epithelial-dendritic cell interactions in allergic disorders","volume":"22","author":"Strickland","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib39","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2017.11.012","article-title":"Thymic stromal lymphopoietin does not activate human basophils","volume":"141","author":"Salabert-Le Guen","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1365-2567.1999.00697.x","article-title":"Granulocyte-macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release by a common pathway: downregulation by sodium","volume":"96","author":"Tedeschi","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2018.10.064_bib41","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1073\/pnas.87.17.6813","article-title":"Interleukin 3 and granulocyte\/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a","volume":"87","author":"Bischoff","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.10.064_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.10.064_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(03)00080-3","article-title":"Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease","volume":"18","author":"Bruhns","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.10.064_bib44","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/eji.201344230","article-title":"Broad requirement for terminal sialic acid residues and Fc\u03b3RIIB for the preventive and therapeutic activity of intravenous immunoglobulins in\u00a0vivo","volume":"44","author":"Schwab","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib45","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1182\/blood-2012-03-415695","article-title":"Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fc\u03b3 receptor for the amelioration of experimental ITP","volume":"119","author":"Leontyev","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.10.064_bib46","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1182\/blood-2011-08-376046","article-title":"IgG1 and IVIg induce inhibitory ITAM signaling through Fc\u03b3RIII controlling inflammatory responses","volume":"119","author":"Aloulou","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.10.064_bib47","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.4049\/jimmunol.1201965","article-title":"Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T\u00a0cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis","volume":"190","author":"Othy","year":"2013","journal-title":"J Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2018.10.064_bib48","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1053\/j.seminhematol.2016.04.007","article-title":"Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for Fc\u03b3RIIB falls by the wayside","volume":"53","author":"Crow","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jaci.2018.10.064_bib49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaci.2010.12.1102","article-title":"Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin","volume":"127","author":"Maddur","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib50","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1182\/blood-2014-05-576835","article-title":"Inhibition of Fc\u03b3R-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and Fc\u03b3RIIb in human macrophages","volume":"124","author":"Nagelkerke","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.10.064_bib51","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/art.38082","article-title":"Contrasting mechanisms of interferon-\u03b1 inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists","volume":"65","author":"Wiedeman","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2018.10.064_bib52","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","article-title":"Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells","volume":"122","author":"Trinath","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.10.064_bib53","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1073\/pnas.0402183101","article-title":"Natural antibodies sustain differentiation and maturation\u00a0of human dendritic cells","volume":"101","author":"Bayry","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.10.064_bib54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/intimm\/dxm052","article-title":"The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model","volume":"19","author":"Blank","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10875-007-9082-2","article-title":"BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer","volume":"27","author":"Le Pottier","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib56","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","article-title":"Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway","volume":"161","author":"Prasad","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib57","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxf099","article-title":"Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus","volume":"14","author":"Shoenfeld","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib58","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaci.2007.01.023","article-title":"Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies","volume":"119","author":"von Gunten","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib59","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41598-017-01404-0","article-title":"IVIG\u00a0regulates the survival of human but not mouse neutrophils","volume":"7","author":"Schneider","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2018.10.064_bib60","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1073\/pnas.0810163105","article-title":"Identification of a receptor required for the anti-inflammatory activity of IVIG","volume":"105","author":"Anthony","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.10.064_bib61","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2009-12-261461","article-title":"IVIg\u00a0modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes","volume":"116","author":"Seite","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.10.064_bib62","doi-asserted-by":"crossref","first-page":"e52875","DOI":"10.1371\/journal.pone.0052875","article-title":"Transcriptional profiling of human dendritic cell populations and models\u2014unique profiles of in\u00a0vitro dendritic cells and implications on functionality and applicability","volume":"8","author":"Lundberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.10.064_bib63","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jaci.2014.06.029","article-title":"Auto-anti-IgE: naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation","volume":"134","author":"Chan","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib64","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20021806","article-title":"Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells","volume":"197","author":"Gonzalez-Espinosa","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.10.064_bib65","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.molimm.2009.05.013","article-title":"Fc\u03b5RI-induced activation by low antigen concentrations results in nuclear signals in the absence of degranulation","volume":"46","author":"Grodzki","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib66","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume":"15","author":"Pincetic","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib67","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2222.2009.03256.x","article-title":"Pathogenesis of chronic urticaria","volume":"39","author":"Kaplan","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"suppl","key":"10.1016\/j.jaci.2018.10.064_bib68","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.jaci.2007.12.389","article-title":"Effect of Intravenous immunoglobulin in chronic urticaria with increased basophil CD203c expression","volume":"121","author":"Amar","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1067\/mai.2001.116291","article-title":"Inhibition of IgE production in\u00a0vitro by intact and fragmented intravenous immunoglobulin","volume":"108","author":"Zhuang","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.064_bib70","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918317330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918317330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:20:32Z","timestamp":1758792032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918317330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0091674918317330"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.10.064","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.10.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}